If you’re wishing to bolster your portfolio with the addition of some ASX blue chip shares, then you might want to consider the ones listed below.
Here’s why I think these blue chip ASX shares could be great long term options for investors:
Cochlear Limited (ASX: COH)
The first blue chip ASX share to consider buying is Cochlear. I think the hearing solutions specialist could be a great long-term investment due to the ageing populations tailwind. As our hearing has a tendency to fade when we get older, I’m confident that ageing populations will lead to growing demand for its high quality products over the next couple of decades. In addition to this, I’m a big fan of the company due to its heavy investment in research and development and the industry’s high barriers to entry. Combined, I expect these to allow Cochlear to maintain its leadership position and limit competition in the future.
CSL Limited (ASX: CSL)
The CSL share price has uncharacteristically been an underperformer in recent months and is trading around 18% lower than its 52-week high. I think this pullback is a buying opportunity for investors with a long-term focus. This is because I’m confident the biotherapeutics company is well-positioned to deliver solid sales and earnings growth over the long term. This is thanks to increasing demand for immunoglobulins, its growing plasma collection network, and its lucrative research and development pipeline.
SEEK Limited (ASX: SEK)
A final blue chip ASX share to consider buying is SEEK. I think the job listings company is one of the best long-term options on the Australian share market. This is due to its growing China-based operations, its market domination in the ANZ market, and investment in future growth opportunities. In FY 2020 SEEK delivered a small increase in revenue to $1,577.4 million. And while FY 2021 will be tough because of the pandemic, I’m confident the company’s growth will accelerate once the crisis passes. This should put it back on a path to achieving its aspirational revenue target of $5 billion later this decade.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- 3 ASX blue-chip shares I would buy at today’s prices
- 3 market-beating ASX blue-chip shares
- Up 38% in August, is the Mesoblast share price a buy?
- 2 ASX shares I would buy right now for both growth and income
- Where to invest $20,000 into ASX shares immediately
James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 3 strong ASX blue chip shares with stellar long term growth prospects appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2YS2961
Leave a Reply